![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ISHITADR.png)
Share the post "Ishita Drugs & Industries ‘s Q2 Update: Profit Falls by 4.76% Year-on-Year"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -25.51 % over the year, substantial increase in net sales/revenue by 8.12 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -46.88 %, Marginal decrease of -12.07% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Ishita Drugs & Industries Ltd.. Profit dropped by -7.14 % Year to Year, Ishita Drugs & Industries Ltd.’s profitability increased by 32.65 % in this quarter.
- EPS over the Year and quarter: EPS declined by -7.14 % Year to Year. EPS increased by 32.65 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 4.395 Cr | Rs. 3.028 Cr | Rs. 3.274 Cr | + 8.12 % | -25.51 % |
| Expenses | Rs. 4.17 Cr | Rs. 2.85 Cr | Rs. 3.04 Cr | + 6.67 % | -27.1 % |
| Operating Profit | Rs. 0.23 Cr | Rs. 0.18 Cr | Rs. 0.23 Cr | + 27.78 % | + 0 % |
| OPM % | 5.23 % | 5.94 % | 7.03 % | + 1.09 % | + 1.8 % |
| Other Income | Rs. 0.096 Cr | Rs. 0.058 Cr | Rs. 0.051 Cr | -12.07 % | -46.88 % |
| Interest | Rs. 0.01 Cr | Rs. 0.01 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0.03 Cr | Rs. 0.03 Cr | Rs. 0.03 Cr | + 0 % | + 0 % |
| Profit before tax | Rs. 0.29 Cr | Rs. 0.2 Cr | Rs. 0.25 Cr | + 25 % | -13.79 % |
| Tax % | 23.64 % | 25 % | 24.81 % | -0.19 % | + 1.17 % |
| Net Profit | Rs. 0.21 Cr | Rs. 0.15 Cr | Rs. 0.2 Cr | + 33.33 % | -4.76 % |
| EPS in Rs | Rs. 0.7 | Rs. 0.49 | Rs. 0.65 | + 32.65 % | -7.14 % |
Today, we’re looking at Ishita Drugs & Industries Ltd.’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a significant year-over-year sales decline of -25.51 %. However, it did see a marginal increase of 8.12 % from the previous quarter. Expenses ticked up slightly by 6.67 % quarter-on-quarter, aligning with the annual decline of -27.1 %. Operating profit, while up 0 % compared to last year, faced a quarter-on-quarter increase of 27.78 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.8 %, but an expansion of 1.09 % sequentially. Other income fell by -12.07 % compared to the last quarter, despite an annual decline of -46.88 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0 %. Profit before tax declined annually by -13.79 % but saw an increase from the preceding quarter by 25 %.
Tax expenses as a percentage of profits increased slightly by 1.17 % compared to last year, with a more notable quarter-on-quarter decrease of -0.19 %. Net profit fell by -4.76 % year-on-year but experienced a 33.33 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -7.14 % but a quarterly rise of 32.65 %. In summary, Ishita Drugs & Industries Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 4.395 Cr | Rs. 3.028 Cr | Rs. 3.274 Cr | + 8.12 % | -25.51 % |
| Expenses | Rs. 4.17 Cr | Rs. 2.85 Cr | Rs. 3.04 Cr | + 6.67 % | -27.1 % |
| Operating Profit | Rs. 0.23 Cr | Rs. 0.18 Cr | Rs. 0.23 Cr | + 27.78 % | + 0 % |
| Net Profit | Rs. 0.21 Cr | Rs. 0.15 Cr | Rs. 0.2 Cr | + 33.33 % | -4.76 % |
| EPS in Rs | Rs. 0.7 | Rs. 0.49 | Rs. 0.65 | + 32.65 % | -7.14 % |
In reviewing Ishita Drugs & Industries Ltd.’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -25.51 % year-on-year, however, there was a minor increase of 8.12 % from the previous quarter. Expenses decreased by -27.1 % compared to the previous year, with a 6.67 % increase quarter-on-quarter. Operating Profit surged by 0 % annually, and saw a 27.78 % increase from the last quarter.
Net Profit showed yearly decrease of -4.76 %, and experienced a 33.33 % increase from the previous quarter. Earnings Per Share (EPS) fell by -7.14 % annually, however rose by 32.65 % compared to the last quarter. In essence, while Ishita Drugs & Industries Ltd. faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Ishita Drugs & Industries Ltd.”]
